z-logo
Premium
Deep Vein Thrombosis and Changes in Coagulation and Fibrinolysis after Gynaecological Operations in Chinese: the Effect of Oral Contraceptives and Malignant Disease
Author(s) -
Tso S. C.,
Wong V.,
Chan Vivian,
Chan T. K.,
Ma H. K.,
Todd D.
Publication year - 1980
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1980.tb06018.x
Subject(s) - medicine , fibrinolysis , thrombosis , plasminogen activator , hysterectomy , antithrombin , venous thrombosis , deep vein , malignancy , surgery , incidence (geometry) , gastroenterology , gynecology , heparin , physics , optics
S ummary . Of 154 Chinese patients who underwent gynaecological operations, four showed a positive 125 I fibrinogen leg scan for venous thrombosis, an overall incidence of 2.6%. In those who were on oral contraceptives and had major pelvic surgery for benign conditions, the incidence was 10.5%; in those who had Wertheim hysterectomy for carcinoma of cervix, it was 6.7%. This confirms the rarity of post‐operative thromboembolism in the Chinese. Fragment E showed a biphasic rise after major operation due to tissue injury and venous thrombosis. In patients with malignancy, the postoperative ‘fibrinolytic shutdown’, represented by decreased plasminogen activator together with increased α 1 , antitrypsin and C inhibitor levels, was more marked. In addition, α 2 macroglobulin level was lower and fell significantly after operation. In patients on oral contraceptives, fragment E levels were higher after surgery and there was no decrease in plasminogen activator levels. Antithrombin III levels did not fall except in three of the four patients with venous thrombosis. A marked increase in fragment E level and a decrease in antithrombin III level might be useful diagnostic markers for postoperative venous thrombosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here